Abstract

BackgroundIt is often difficult to diagnose salivary gland tumors that exhibit basaloid features differentially. The aim of this study was to identify additional morphological and immunohistochemical characteristics that can aid the diagnosis of basal cell adenocarcinoma (BCAC) of the salivary gland.Methods and resultsIn total, 29 basal cell neoplasms [eight BCACs, 11 basal cell adenomas (BCAs) with capsular invasion, and 10 BCAs without capsular invasion] and 10 cases of adenoid cystic carcinomas (ACCs) were subjected to histopathology and immunohistochemical analyses for CK7, CK5/6, SMA, p63, calponin, p53, c-erbB2, CD117, β-catenin, EGFR, VEGF, Ki-67, and S100P protein expression. Compared to BCA without capsular invasion, the BCACs and BCAs with capsular invasion were more likely to be larger and have solid or cribriform patterns. Most BCACs and BCAs exhibited nuclear β-catenin expression. In all basal cell neoplasm cases, the clinical course after surgery with or without radiotherapy was indolent. β-catenin, CK5/6, CD117, and S100P protein were helpful for differentiating basal cell neoplasms from ACC.ConclusionsBCAs with capsular invasion shared several pathological features with BCACs, including a large size and frequent cribriform patterns but the malignant potential of these tumors seems highly limited and should be reexamined. β-catenin immunostaining may aid the differential diagnosis between basal cell neoplasms and ACCs.Virtual slidesThe virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/9637819101988153

Highlights

  • Basal cell adenocarcinoma (BCAC) is a rare malignant tumor of the salivary gland that was included in the 1991 World Health Organization (WHO) classification

  • The diagnosis of basal cell adenocarcinoma (BCAC) is hampered by the fact that they can have a solid or cribriform pattern that mimics the features of adenoid cystic carcinoma (ACC)

  • The present study showed that differential diagnosis between basal cell adenomas (BCAs), BCAC, and ACC was unlikely to be aided by the various epithelial and myoepithelial/basal cell markers that were tested

Read more

Summary

Introduction

Basal cell adenocarcinoma (BCAC) is a rare malignant tumor of the salivary gland that was included in the 1991 World Health Organization (WHO) classification. A solid consensus regarding the features that can be used to distinguish BCAC from basal cell adenoma (BCA) has not been obtained. The present study sought to identify the clinical, histopathological, and immunohistochemical characteristics of BCAC that allow it to be differentiated from BCA and ACC. It is often difficult to diagnose salivary gland tumors that exhibit basaloid features differentially. The aim of this study was to identify additional morphological and immunohistochemical characteristics that can aid the diagnosis of basal cell adenocarcinoma (BCAC) of the salivary gland

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.